International Journal of Infectious Diseases
Volume 14, Issue 2 , Pages e161-e163 , February 2010

Severe Guillain–Barré syndrome following primary infection with varicella zoster virus in an adult

Received 15 September 2008 ,Accepted 21 March 2009.

References 

  1. Ropper AH, Wijdicks EP, Truax BT. Guillain–Barré syndrome. Philadelphia: FA Davis; 1991;
  2. Goetz CG. Textbook of clinical neurology. 3rd ed.. USA: Elseviers; 1999;
  3. Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedant infections in Guillain–Barré syndrome: a case–control study. Neurology. 1998;51:1110–1115
  4. Pavone P, Maccarrone F, Sorge A, Piccolo G, Greco F, Caruso P, et al. Guillain–Barré syndrome after varicella zoster virus infections. A case report. Minerva Pediatr. 2002;54:259–262
  5. da Rosa-Santos OL, Moreira AM, Golfetto CA, Maceira JP, Ramos-e-Silva M. Guillain–Barré syndrome associated with varicella-zoster infection. Int J Dermatol. 1996;35:603–604
  6. Arruda WO, Aguiar LR, Sandoval PR. Guillain–Barré syndrome after varicella-zoster infection. Case report. Arq Neuropsiquiatr. 1987;45:430–433
  7. Sanders EA, Peters AC, Gratana JW, Hughes RA. Guillain–Barré syndrome after varicella-zoster infection. Report of two cases. J Neurol. 1987;234:437–439
  8. Rabbani M, Gupta D. Guillain–Barré syndrome following herpes zoster: a case report and review of literature. Jpn J Med. 1990;29:397–398
  9. Lee B. Review of varicella zoster seroepidemiology in India and South-east Asia. Trop Med Int Health. 1998;3:886–890
  10. Yoshikawa T, Suga S, Kozawa T, Kawaguchi S, Asano Y. Persistence of protective immunity after postexposure prophylaxis of varicella with oral aciclovir in the family setting. Arch Dis Child. 1998;78:61–63
  11. White CB, Hawley WZ, Harford DJ. The pediatric resident susceptible to varicella: proving immunity through postexposure prophylaxis with oral acyclovir. Pediatr Infect Dis J. 1994;13:743–745
  12. Sheikh KA, Ho TW, Nachamkin I, Li CY, Cornblath DR, Asbury AK, et al. Molecular mimicry in Guillain–Barré syndrome. Ann N Y Acad Sci. 1998;845:307–321
  13. The Nerve Research Foundation. Annual report 2006. Sydney, Australia: The Nerve Research Foundation; 2006, p. 8-9.
  14. Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M, et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome. Neurology. 2005;64:856–860
  15. Yuki N, Kuwabara S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor-sensory neuropathy share a common immunological profile. J Neurol Sci. 1999;168:121–126
  16. Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J, Ung H, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré syndrome. Ann Neurol. 1999;45:168–173

PII: S1201-9712(09)00155-6

doi: 10.1016/j.ijid.2009.03.019

International Journal of Infectious Diseases
Volume 14, Issue 2 , Pages e161-e163 , February 2010

Article Tools